# Novel Laboratories, Inc. d.b.a Lupin Somerset – FDA Inspection, Apr 17, 2026

Source: https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/3929d635-0f63-4a0a-b47f-d35102bc3d33
Source feed: FDA_Inspections

> FDA inspection 1306616 of Novel Laboratories, Inc. d.b.a Lupin Somerset, April 17, 2026. 3 citations under 21 CFR part 211. Form 483 issued. 18 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1306616
- Company Name: Novel Laboratories, Inc. d.b.a Lupin Somerset
- Inspection Date: 2026-04-17
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 3

## Related Documents

- [FDA Inspection 1285934 - 2025-10-10](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/68e0ace3-c682-4a1c-bb76-34bb3f2712bd)
- FDA Inspection 1259938 - 2025-01-31
- [FDA Inspection 1235495 - 2024-05-17](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/da7fdbc2-3b68-4bd4-bebb-447e90336803)
- [FDA Inspection 1197049 - 2023-01-13](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/c29bdd8e-f68a-4554-b27f-a094c6c578d0)
- FDA Inspection 1168160 - 2022-03-30

## Related Officers

- [Company Rep](https://www.keypedia.com/people/anthony-j-donato/a6dd6e14-529e-4b23-9b5f-02c88afb80ae)
- [Company Rep](https://www.keypedia.com/people/daniel-t-lee/8147e5b2-2065-42e3-b86c-36c0231f74cc)

Company: https://www.keypedia.com/companies/novel-laboratories-inc-dba-lupin-somerset/53a42119-c077-49fb-b739-db29c2b99391

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248